TWD 19.7
(-0.51%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 870 Thousand TWD | -66.11% |
2022 | 2.56 Million TWD | -41.66% |
2021 | 4.4 Million TWD | -28.91% |
2020 | 6.18 Million TWD | 0.0% |
2019 | - TWD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q1 | 5.49 Million TWD | 531.38% |
2024 Q2 | 5.49 Million TWD | 6.04% |
2023 FY | 870 Thousand TWD | -66.11% |
2023 Q2 | 1.62 Million TWD | 0.0% |
2023 Q1 | - TWD | -100.0% |
2023 Q3 | - TWD | -100.0% |
2023 Q4 | 870 Thousand TWD | 0.0% |
2022 Q3 | 653 Thousand TWD | 0.0% |
2022 Q4 | 2.56 Million TWD | 293.11% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Bio Preventive Medicine Corp. | 113.44 Million TWD | 99.233% |
Genomics BioSci & Tech. Co.,Ltd. | 283.61 Million TWD | 99.693% |
Taiwan Bio Therapeutics Co., Ltd | 268.62 Million TWD | 99.676% |
NaviFUS Corp. | 32.69 Million TWD | 97.339% |
G&E Herbal Biotechnology Co., Ltd. | 5.43 Million TWD | 83.981% |
TaiRx, Inc. | 12.28 Million TWD | 92.919% |
Sinew Pharma Inc. | 6.46 Million TWD | 86.541% |
Lin BioScience, Inc. | 42.87 Million TWD | 97.971% |
TaiwanJ Pharmaceuticals Co., Ltd. | 1.17 Million TWD | 25.705% |
Lumosa Therapeutics Co., Ltd. | 12.61 Million TWD | 93.101% |
Anti-Microbial Savior BioteQ Co., Ltd | 1.38 Million TWD | 37.093% |
SYN-TECH Chem. & Pharm. Co., Ltd. | 402.75 Million TWD | 99.784% |
AP Biosciences Inc | 82.07 Million TWD | 98.94% |
Sunmax Biotechnology Co., Ltd. | 174.08 Million TWD | 99.5% |
RBC Bioscience Corporation | 487.36 Million TWD | 99.821% |
Syngen Biotech Co.,Ltd. | 681.76 Million TWD | 99.872% |
EirGenix Inc. | 465.16 Million TWD | 99.813% |
Enimmune corporation | 45.73 Million TWD | 98.098% |
Lukas Biomedical Inc. | 82.55 Million TWD | 98.946% |
BRIM Biotechnology, Inc. | 3.59 Million TWD | 75.78% |
3D Global Biotech Inc. | 10.37 Million TWD | 91.618% |
TaiMed Biologics Inc. | 750.85 Million TWD | 99.884% |
Mycenax Biotech Inc. | 726.27 Million TWD | 99.88% |
TCI GENE Inc. | 6.79 Million TWD | 87.196% |
SynCore Biotechnology Co.,Ltd | 2.11 Million TWD | 58.846% |
Oneness Biotech Co., Ltd. | 397.95 Million TWD | 99.781% |
Eusol Biotech Co.,Ltd. | 4.35 Million TWD | 80.018% |
Feng Chi Biotech Corp. | 10.79 Million TWD | 91.943% |
NeoCore Technology Co., Ltd. | 96.89 Million TWD | 99.102% |
TWi Biotechnology, Inc. | 7.97 Million TWD | 89.085% |
Neith Corporation | 3.54 Million TWD | 75.431% |
Sunny Pharmtech Inc. | 391.42 Million TWD | 99.778% |
VBI | - TWD | -Infinity% |
Ever Supreme Bio Technology Co., Ltd | 5.89 Million TWD | 85.249% |
GeneReach Biotechnology Corp. | 257.03 Million TWD | 99.662% |
Shine-On BioMedical Co.,Ltd. | 538 Thousand TWD | -61.71% |
CHO Pharma, Inc. | - TWD | -Infinity% |
Andros Pharmaceuticals Co.,Ltd | 27.12 Million TWD | 96.792% |
MegaPro Biomedical Co., Ltd | 8.31 Million TWD | 89.541% |
Visgeneer Inc. | 158.6 Million TWD | 99.451% |
Greenyn Biotechnology Co., Ltd | 196.13 Million TWD | 99.556% |
BioLASCO Taiwan Co., Ltd. | 58.2 Million TWD | 98.505% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 417.01 Million TWD | 99.791% |
Sagittarius Life Science Corp | 13.32 Million TWD | 93.47% |
BioGend Therapeutics Co., Ltd. | 13.09 Million TWD | 93.355% |
GlycoNex Incorporation | 900 Thousand TWD | 3.333% |
Medigen Biotechnology Corp. | 2.91 Billion TWD | 99.97% |
Pharmosa Biopharm Inc. | 144.36 Million TWD | 99.397% |
PharmaEngine, Inc. | 14.8 Million TWD | 94.125% |
Intech Biopharm Corporation | 1.43 Billion TWD | 99.939% |
Taiwan Advance Bio-Pharmaceutical Inc. | 320.13 Million TWD | 99.728% |
BiOptic Inc. | 93.19 Million TWD | 99.067% |
TaiGen Biopharmaceuticals Holdings Limited | 74.68 Million TWD | 98.835% |
Senhwa Biosciences, Inc. | 9.6 Million TWD | 90.938% |
NatureWise Biotech & Medicals Corporation | 10.68 Million TWD | 91.855% |
OBI Pharma, Inc. | 501.05 Million TWD | 99.826% |
Savior Lifetec Corporation | 270.37 Million TWD | 99.678% |
Great Novel Therapeutics Biotech & Medicals | 14.37 Million TWD | 93.948% |
Level Biotechnology Inc. | 13.5 Million TWD | 93.557% |
Medigen Vaccine Biologics Corporation | 1.97 Billion TWD | 99.956% |
Meribank Biotech Co., Ltd | 34.03 Million TWD | 97.444% |
Acepodia, Inc. | 273.81 Million TWD | 99.682% |
Caliway Biopharmaceuticals Co., Ltd. | 20.45 Million TWD | 95.747% |